Role of lymphadenectomy in the management of urothelial carcinoma of the bladder and the upper urinary tract

International Journal of Urology

Volumn 19, Issue 8, 2012, Pages 710-721

  Kondo, Tsunenori ^a   Tanabe, Kazunari ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Bladder neoplasm; Kidney pelvis; Lymph node excision; Transitional cell carcinoma; Ureteral neoplasms

Indexed keywords

BLADDER CANCER; BLADDER CARCINOMA; CANCER STAGING; CANCER SURVIVAL; CYSTECTOMY; LYMPHADENECTOMY; PELVIS LYMPH NODE; PRIORITY JOURNAL; REVIEW; SURGICAL RISK; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; URINARY TRACT CARCINOMA;

CARCINOMA, TRANSITIONAL CELL; HUMANS; LYMPH NODE EXCISION; NEOPLASM STAGING; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 84864309625     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2012.03009.x     Document Type: Review

References (67)

1. Capitanio U, Becker F, Blute ML etal. Lymph node dissection in renal cell carcinoma. Eur. Urol. 2011; 60: 1212-20.
2. Miki J, Egawa S. The role of lymph node dissection in the management of prostate cancer. Int. J. Clin. Oncol. 2011; 16: 195-202.
3. Kitamura H, Masumori N, Tsukamoto T. Role of lymph node dissection in management of bladder cancer. Int. J. Clin. Oncol. 2011; 16: 179-85.
4. Roscigno M, Brausi M, Heidenreich A etal. Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer. Eur. Urol. 2011; 60: 776-83.
5. Crispen PL, Breau RH, Allmer C etal. Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates. Eur. Urol. 2011; 59: 18-23.
6. DiMarco DS, Zincke H, Sebo TJ, Slezak J, Bergstralh EJ, Blute ML. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. J. Urol. 2005; 173: 1121-5.
7. Briganti A, Blute ML, Eastham JH etal. Pelvic lymph node dissection in prostate cancer. Eur. Urol. 2009; 55: 1251-65.
8. Capitanio U, Jeldres C, Patard JJ etal. Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma. BJU Int. 2009; 103: 33-7.
9. Stein JP, Lieskovsky G, Cote R etal. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1, 054 patients. J. Clin. Oncol. 2001; 19: 666-75.
10. Zigeuner R, Pummer K. Urothelial carcinoma of the upper urinary tract: surgical approach and prognostic factors. Eur. Urol. 2008; 53: 720-31.
11. Leissner J, Ghoneim MA, Abol-Enein H etal. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J. Urol. 2004; 171: 139-44.
12. Stenzl A, Cowan NC, De Santis M etal. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur. Urol. 2011; 59: 1009-18.
13. Dretler SP, Ragsdale BD, Leadbetter WF. The value of pelvic lymphadenectomy in the surgical treatment of bladder cancer. J. Urol. 1973; 109: 414-16.
14. Skinner DG. Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J. Urol. 1982; 128: 34-6.
15. Wishnow KI, Johnson DE, Ro JY, Swanson DA, Babaian RJ, von Eschenbach AC. Incidence, extent and location of unsuspected pelvic lymph node metastasis in patients undergoing radical cystectomy for bladder cancer. J. Urol. 1987; 137: 408-10.
16. Lerner SP, Skinner DG, Lieskovsky G etal. The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. J. Urol. 1993; 149: 758-64; discussion 764-5.
17. Vieweg J, Whitmore WF Jr, Herr HW etal. The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. The Memorial Sloan-Kettering Cancer Center experience. Cancer 1994; 73: 3020-8.
18. Stein JP, Skinner DG. The role of lymphadenectomy in high-grade invasive bladder cancer. Urol. Clin. North Am. 2005; 32: 187-97.
19. Sherif A, De La Torre M, Malmstrom PU, Thorn M. Lymphatic mapping and detection of sentinel nodes in patients with bladder cancer. J. Urol. 2001; 166: 812-15.
20. Liedberg F, Chebil G, Davidsson T, Gudjonsson S, Mansson W. Intraoperative sentinel node detection improves nodal staging in invasive bladder cancer. J. Urol. 2006; 175: 84-8; discussion 88-9.
21. Roth B, Wissmeyer MP, Zehnder P etal. A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. Eur. Urol. 2010; 57: 205-11.
22. Jensen JB, Ulhoi BP, Jensen KM. Lymph node mapping in patients with bladder cancer undergoing radical cystectomy and lymph node dissection to the level of the inferior mesenteric artery. BJU Int. 2010; 106: 199-205.
23. Vazina A, Dugi D, Shariat SF, Evans J, Link R, Lerner SP. Stage specific lymph node metastasis mapping in radical cystectomy specimens. J. Urol. 2004; 171: 1830-4.
24. Zehnder P, Studer UE, Skinner EC etal. Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J. Urol. 2011; 186: 1261-8.
25. Thurairaja R, Studer UE, Burkhard FC. Indications, extent, and benefits of pelvic lymph node dissection for patients with bladder and prostate cancer. Oncologist 2009; 14: 40-51.
26. Urinary bladder (ICD-O C67). In: Sobin LH, Gospodarowicz MK, Wittekind CH (eds). TNM Classification of Malignant Tumors, 7th edn. Wiley-Liss, New York, 2009; 262-5.
27. Poulsen AL, Horn T, Steven K. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J. Urol. 1998; 160: 2015-19.
28. Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J. Urol. 2002; 167: 1295-8.
29. Bochner BH, Cho D, Herr HW, Donat M, Kattan MW, Dalbagni G. Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping. J. Urol. 2004; 172: 1286-90.
30. Abdel-Latif M, Abol-Enein H, El-Baz M, Ghoneim MA. Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis. J. Urol. 2004; 172: 85-9.
31. Stein JP, Penson DF, Cai J etal. Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. J. Urol. 2007; 177: 876-81; discussion 881-2.
32. Dangle PP, Gong MC, Bahnson RR, Pohar KS. How do commonly performed lymphadenectomy templates influence bladder cancer nodal stage? J. Urol. 2010; 183: 499-503.
33. Abol-Enein H, Tilki D, Mosbah A etal. Does the extent of lymphadenectomy in radical cystectomy for bladder cancer influence disease-free survival? A prospective single-center study. Eur. Urol. 2011; 60: 572-7.
34. Miocinovic R, Gong MC, Ghoneim IA, Fergany AF, Hansel DE, Stephenson AJ. Presacral and retroperitoneal lymph node involvement in urothelial bladder cancer: results of a prospective mapping study. J. Urol. 2011; 186: 1269-73.
35. Dhar NB, Klein EA, Reuther AM, Thalmann GN, Madersbacher S, Studer UE. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J. Urol. 2008; 179: 873-8.
36. Mills RD, Turner WH, Fleischmann A, Markwalder R, Thalmann GN, Studer UE. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J. Urol. 2001; 166: 19-23.
37. Konety BR, Joslyn SA, O'Donnell MA. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base. J. Urol. 2003; 169: 946-50.
38. Koppie TM, Vickers AJ, Vora K, Dalbagni G, Bochner BH. Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed? Cancer 2006; 107: 2368-74.
39. Capitanio U, Suardi N, Shariat SF etal. Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancer. BJU Int. 2009; 103: 1359-62.
40. Stein JP, Cai J, Groshen S, Skinner DG. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J. Urol. 2003; 170: 35-41.
41. Steven K, Poulsen AL. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only. J. Urol. 2007; 178: 1218-23; discussion 1223-4.
42. Brossner C, Pycha A, Toth A, Mian C, Kuber W. Does extended lymphadenectomy increase the morbidity of radical cystectomy? BJU Int. 2004; 93: 64-6.
43. Leissner J, Hohenfellner R, Thuroff JW, Wolf HK. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int. 2000; 85: 817-23.
44. Karl A, Carroll PR, Gschwend JE etal. The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer. Eur. Urol. 2009; 55: 826-35.
45. Batata MA, Whitmore WF, Hilaris BS, Tokita N, Grabstald H. Primary carcinoma of the ureter: a prognostic study. Cancer 1975; 35: 1626-32.
46. Grabstald H, Whitmore WF, Melamed MR. Renal pelvic tumors. JAMA 1971; 218: 845-54.
47. McCarron JP Jr, Chasko SB, Gray GF Jr. Systematic mapping of nephroureterectomy specimens removed for urothelial cancer: pathological findings and clinical correlations. J. Urol. 1982; 128: 243-6.
48. Akaza H, Koiso K, Niijima T. Clinical evaluation of urothelial tumors of the renal pelvis and ureter based on a new classification system. Cancer 1987; 59: 1369-75.
49. Skinner DG. Technique of nephroureterectomy with regional lymph node dissection. Urol. Clin. North Am. 1978; 5: 252-60.
50. Komatsu H, Tanabe N, Kubodera S, Maezawa H, Ueno A. The role of lymphadenectomy in the treatment of transitional cell carcinoma of the upper urinary tract. J. Urol. 1997; 157: 1622-4.
51. Miyake H, Hara I, Gohji K, Arakawa S, Kamidono S. The significance of lymphadenectomy in transitional cell carcinoma of the upper urinary tract. Br. J. Urol. 1998; 82: 494-8.
52. Renal plevis and ureter (ICD-O C65, C66). In: Sobin LH, Gospodarowicz MK, Wittekind CH (eds). TNM Classification of Malignant Tumors, 7th edn. Wiley-Liss, New York, 2009; 258-61.
53. Kondo T, Nakazawa H, Ito F, Hashimoto Y, Toma H, Tanabe K. Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract. Urology 2007; 69: 265-9.
54. Assouad J, Riquet M, Foucault C, Hidden G, Delmas V. Renal lymphatic drainage and thoracic duct connections: implications for cancer spread. Lymphology 2006; 39: 26-32.
55. Kondo T, Nakazawa H, Ito F, Hashimoto Y, Toma H, Tanabe K. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract. J. Urol. 2007; 178: 1212-17.
56. Brausi MA, Gavioli M, De Luca G etal. Retroperitoneal Lymph Node Dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative Transitional Cell Carcinoma (TCC) of the upper urinary tract: impact on survival. Eur. Urol. 2007; 52: 1414-20.
57. Roscigno M, Cozzarini C, Bertini R etal. Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract. Eur. Urol. 2008; 53: 794-802.
58. Roscigno M, Shariat SF, Margulis V etal. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J. Urol. 2009; 181: 2482-9.
59. Roscigno M, Shariat SF, Margulis V etal. The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed? Eur. Urol. 2009; 56: 512-18.
60. Kondo T, Hashimoto Y, Kobayashi H etal. Template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract: impact on patient survival. Int. J. Urol. 2010; 17: 848-54.
61. Abe T, Shinohara N, Muranaka M etal. Role of lymph node dissection in the treatment of urothelial carcinoma of the upper urinary tract: multi-institutional relapse analysis and immunohistochemical re-evaluation of negative lymph nodes. Eur. J. Surg. Oncol. 2010; 36: 1085-91.
62. Lughezzani G, Jeldres C, Isbarn H etal. A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma. Urology 2010; 75: 118-24.
63. Burger M, Shariat SF, Fritsche HM etal. No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study. World J. Urol. 2011; 29: 465-72.
64. PDQ®- NCI's Comprehensive Cancer Database. Transitional Cell Cancer of the Renal Pelvis and Ureter Treatment (PDQ®). National Cancer Institute, Rockville, USA, 2011.
65. Roupret M, Zigeuner R, Palou J etal. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur. Urol. 2011; 59: 584-94.
66. Bolenz C, Shariat SF, Fernandez MI etal. Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density. BJU Int. 2009; 103: 302-6.
67. Blom JH, van Poppel H, Marechal JM etal. Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881 editorial by Urs E. Studer and Frederic D. Birkhauser on pp. x-y of this issue. Eur. Urol. 2009; 55: 28-34.